These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole. Horn J Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214 [TBL] [Abstract][Full Text] [Related]
23. [Drug of the month. Lansoprazole (DakaR)]. Scheen AJ Rev Med Liege; 1995 Mar; 50(3):133-4. PubMed ID: 7724943 [No Abstract] [Full Text] [Related]
24. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis. Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975 [TBL] [Abstract][Full Text] [Related]
25. The use of omeprazole in the pediatric population. Walters JK; Zimmermann AE; Souney PF; Katona BG Ann Pharmacother; 1998 Apr; 32(4):478-81. PubMed ID: 9562145 [No Abstract] [Full Text] [Related]
26. Acid-related disorders and use of antisecretory medication. Lassen AT Dan Med Bull; 2007 Feb; 54(1):18-30. PubMed ID: 17349216 [No Abstract] [Full Text] [Related]
27. Proton-pump inhibition for acid-related disease. Holt S South Med J; 1991 Sep; 84(9):1078-87. PubMed ID: 1653998 [TBL] [Abstract][Full Text] [Related]
28. Acid control and regression of Barrett's esophagus: is the glass half full or half empty? Castell DO; Katz PO Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786 [No Abstract] [Full Text] [Related]
29. Proton pump inhibitor co-therapy with clopidogrel: is there GI benefit or cardiovascular harm? Laine L Gastroenterology; 2011 Mar; 140(3):769-72. PubMed ID: 21266209 [No Abstract] [Full Text] [Related]
30. [Advances in the knowledge of peptic-acid dependent diseases]. Mazure PA; Pigliacampo J Acta Gastroenterol Latinoam; 1989; 19(3):165-73. PubMed ID: 2576850 [No Abstract] [Full Text] [Related]
31. [Proton pump inhibitors, a family of drugs in continuous expansion]. Pellicano R Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085 [No Abstract] [Full Text] [Related]
32. Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis. Illueca M; Wernersson B; Henderson C; Lundborg P J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):733-40. PubMed ID: 20808247 [TBL] [Abstract][Full Text] [Related]
34. Effect of short-term treatment with regular or high doses of omeprazole on the detection of Helicobacter pylori in bleeding peptic ulcer patients. Udd M; Miettinen P; Palmu A; Julkunen R Scand J Gastroenterol; 2003 Jun; 38(6):588-93. PubMed ID: 12825865 [TBL] [Abstract][Full Text] [Related]
35. Potent acid inhibition: summary of the evidence and clinical application. Mearin F; Ponce J Drugs; 2005; 65 Suppl 1():113-26. PubMed ID: 16335865 [No Abstract] [Full Text] [Related]
36. [Relapse of peptic ulcer after quick healing induced by proton pump inhibitors]. Tsukamoto Y; Niwa Y; Arisawa T Nihon Rinsho; 1992 Jan; 50(1):174-80. PubMed ID: 1371814 [TBL] [Abstract][Full Text] [Related]
37. Only one proton-pump inhibitor for formulary. Hopefl A Am J Health Syst Pharm; 1996 Dec; 53(23):2882, 2884. PubMed ID: 8957352 [No Abstract] [Full Text] [Related]